Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-02

Clinical Trial Update: Study to Demonstrate Non-Inferior Efficacy and Safety of CinnoRA® Versus Humira® for Treatment of Active RA [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing CinnoRA to Humira for active rheumatoid arthritis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CinnoRA (adalimumab biosimilar)
  • Humira (adalimumab)

Snippet

Sponsor: Cinnagen | Conditions: Active Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2021-02-02